COVIDIEN PLC COM SHS NEW (IRELAND)
COV
COV was delisted on the 26th of January, 2015.
758 hedge funds and large institutions have $43.7B invested in COVIDIEN PLC COM SHS NEW (IRELAND) in 2014 Q4 according to their latest regulatory filings, with 115 funds opening new positions, 190 increasing their positions, 336 reducing their positions, and 68 closing their positions.
69% more first-time investments, than exits
New positions opened: 115 | Existing positions closed: 68
48% more funds holding in top 10
Funds holding in top 10: 60 → 89 (+29)
26% more capital invested
Capital invested by funds: $34.7B → $43.7B (+$9B)
5% more funds holding
Funds holding: 720 → 758 (+38)
43% less repeat investments, than reductions
Existing positions increased: 190 | Existing positions reduced: 336
77% less call options, than puts
Call options by funds: $335M | Put options by funds: $1.48B
Top Buyers
Top Sellers
COV Hedge Fund Activity: Q4 2014 in Review
758 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in COVIDIEN PLC COM SHS NEW (IRELAND) (COV) for Q4 2014, worth a combined $43.7B — up 26% from $34.7B a quarter earlier.
Buyers outnumbered sellers: 115 funds opened new COV positions and 68 closed out — a net gain of 47 holders — while 190 added to existing stakes and 336 trimmed.
The largest buyer was Pentwater Capital Management, adding an estimated $372M. The largest seller was Fidelity Investments, cutting an estimated $931M.
- 758 institutional investors held COVIDIEN PLC COM SHS NEW (IRELAND) (COV) as of Q4 2014, up from 720 in Q3 2014.
- Funds reported $43.7B of COVIDIEN PLC COM SHS NEW (IRELAND) stock for Q4 2014, up 26% quarter-over-quarter.
- 115 funds opened new COVIDIEN PLC COM SHS NEW (IRELAND) positions in Q4 2014 and 68 closed out, a net change of +47 holders.
- The largest COVIDIEN PLC COM SHS NEW (IRELAND) buyer in Q4 2014 was Pentwater Capital Management, an estimated $372M added.
- The largest COVIDIEN PLC COM SHS NEW (IRELAND) seller in Q4 2014 was Fidelity Investments, an estimated $931M sold.
Based on aggregated 13F filings for Q4 2014.